<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01302548</url>
  </required_header>
  <id_info>
    <org_study_id>20101227</org_study_id>
    <nct_id>NCT01302548</nct_id>
  </id_info>
  <brief_title>The Effect Of Wound Irrigation With Irrisept™ Delivery System On Abscess Healing In Patients Presenting To The Emergency Department</brief_title>
  <official_title>THE EFFECT OF WOUND IRRIGATION WITH IRRISEPT™ Delivery System ON ABSCESS HEALING IN PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Irrimax Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if wound cleansing and irrigation using the
      IRRISEPT Chlorhexidine Gluconate(CHG)solution, applying a given volume with a pressurized
      stream, will improve the outcome for infected abscesses in patients that present in the
      emergency department.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study did not accrue the required number of study subjects.
  </why_stopped>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Abscess Healing Based on Abscess Measurement Scale</measure>
    <time_frame>48 hours</time_frame>
    <description>The abscess healing process will use two methods: 1) &quot;usual method&quot; includes saline irrigation and/or incision &amp; drainage, and 2) the use of IRRISEPT solution. The Abscess Measurement Scale was measured using a centimeter ruler.
Scale 8cm - 10cm = Severe 6cm - 8cm = Moderate/severe 4cm - 6cm = Moderate 2cm - 4cm = Mild/moderate 0cm - 2cm = Mild</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Prescribed Oral Antibiotics</measure>
    <time_frame>48 hours</time_frame>
    <description>Number of patients prescribed oral antibiotics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abscess Measurement Using a Abscess Measurement Scale in Methicillin-resistant Staphylococcus Aureus (MRSA) Positive Patients.</measure>
    <time_frame>48 hours</time_frame>
    <description>The Abscess Measurement Scale was measured using a centimeter ruler.
Scale 8cm - 10cm = Severe 6cm - 8cm = Moderate/severe 4cm - 6cm = Moderate 2cm - 4cm = Mild/moderate 0cm - 2cm = Mild</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Abscess</condition>
  <arm_group>
    <arm_group_label>IRRISEPT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device containing sterile water and chlorhexidine gluconate (CHG)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The usual care method will either be the saline irrigation or incision and drainage depending on the physicians discretion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IRRISEPT</intervention_name>
    <description>Device containing sterile water and chlorhexidine gluconate (CHG)</description>
    <arm_group_label>IRRISEPT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>The usual care method will either be the saline irrigation or incision and drainage depending on the physicians discretion.</description>
    <arm_group_label>Usual Care</arm_group_label>
    <other_name>Saline irrigation</other_name>
    <other_name>Incision &amp; Drainage</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Immunocompetent individuals 12 years of age or older with an uncomplicated abscess

          -  Patient must be able to answer questions and be medically stable as defined by the
             Emergency Department physician

          -  Patient must voluntarily participate in the study

        Exclusion Criteria:Patients with any of the following are excluded:

          -  Currently receiving antibiotics or received antibiotics within last 72 hours

          -  Evidence of systemic infection (fever, aches, chills, nausea)

          -  Requires admission to the hospital for infection or for any other reason(s)

          -  Abscess caused by a human or animal bite

          -  Prior history of hypersensitivity or allergy to Chlorhexidine Gluconate (CHG)

          -  Immunodeficiency (Examples: HIV Positive, Crohns Disease, Systemic Lupus
             Erythematosus, Addison's disease, psoriasis, splenectomy, leukemia, cancer on
             chemotherapy)

          -  Currently on any immune-modifying medication (Examples: prednisone, antivirals)

          -  History of chronic skin infection (3 or more in the past year)

          -  Chronic medical problem, for example end-stage heart, liver, kidney, or lung disease,
             diabetes mellitus, peripheral vascular disease, history of organ transplant

          -  Mental illness including but not limited to substance abuse, dementia, schizophrenia
             or mentally handicapped or challenged

          -  Incarcerated

          -  Patient is pregnant or thinks she may be pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard F Petrik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shands Hospital at the University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2010</study_first_submitted>
  <study_first_submitted_qc>February 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2011</study_first_posted>
  <results_first_submitted>September 9, 2013</results_first_submitted>
  <results_first_submitted_qc>February 28, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 7, 2014</results_first_posted>
  <last_update_submitted>February 28, 2014</last_update_submitted>
  <last_update_submitted_qc>February 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Abscess</keyword>
  <keyword>Wound Irrigation</keyword>
  <keyword>Wound Debridement</keyword>
  <keyword>Wound Healing</keyword>
  <keyword>Incision and drainage</keyword>
  <keyword>Chlorhexidine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Abscess</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>IRRISEPT</title>
          <description>Device containing sterile water and chlorhexidine gluconate (CHG)</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>The usual care method will either be the saline irrigation or incision and drainage depending on the physicians discretion.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IRRISEPT</title>
          <description>Device containing sterile water and chlorhexidine gluconate (CHG)</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>The usual care method will either be the saline irrigation or incision and drainage depending on the physicians discretion.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
            <count group_id="B2" value="19"/>
            <count group_id="B3" value="33"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.42" spread="9.04"/>
                    <measurement group_id="B2" value="24.83" spread="9.81"/>
                    <measurement group_id="B3" value="27.87" spread="10.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Abscess Healing Based on Abscess Measurement Scale</title>
        <description>The abscess healing process will use two methods: 1) &quot;usual method&quot; includes saline irrigation and/or incision &amp; drainage, and 2) the use of IRRISEPT solution. The Abscess Measurement Scale was measured using a centimeter ruler.
Scale 8cm – 10cm = Severe 6cm – 8cm = Moderate/severe 4cm – 6cm = Moderate 2cm – 4cm = Mild/moderate 0cm – 2cm = Mild</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IRRISEPT</title>
            <description>Device containing sterile water and chlorhexidine gluconate (CHG)</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>The usual care method will either be the saline irrigation or incision and drainage depending on the physicians discretion.</description>
          </group>
        </group_list>
        <measure>
          <title>Abscess Healing Based on Abscess Measurement Scale</title>
          <description>The abscess healing process will use two methods: 1) &quot;usual method&quot; includes saline irrigation and/or incision &amp; drainage, and 2) the use of IRRISEPT solution. The Abscess Measurement Scale was measured using a centimeter ruler.
Scale 8cm – 10cm = Severe 6cm – 8cm = Moderate/severe 4cm – 6cm = Moderate 2cm – 4cm = Mild/moderate 0cm – 2cm = Mild</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.750" spread="0.6216"/>
                    <measurement group_id="O2" value="2.833" spread="0.9852"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Ho: There is not a significant difference between the use of IRRISEPT solution and the &quot;usual care methods&quot; on abscess healing.
This study did not enroll an adequate number of patients to meet sufficient power.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.7970</p_value>
            <p_value_desc>This is unadjusted.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>Degrees of freedom = 28</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>.0833</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>.8609</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-.5738</ci_lower_limit>
            <ci_upper_limit>.7405</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Prescribed Oral Antibiotics</title>
        <description>Number of patients prescribed oral antibiotics</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IRRISEPT</title>
            <description>Device containing sterile water and chlorhexidine gluconate (CHG)</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>The usual care method will either be the saline irrigation or incision and drainage depending on the physicians discretion.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Prescribed Oral Antibiotics</title>
          <description>Number of patients prescribed oral antibiotics</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Ho: There is not a significant difference between the proportion of patients requiring antibiotics after the use of IRRISEPT solution vs. the &quot;usual care methods&quot; on abscess healing.
This study did not enroll an adequate number of patients to meet sufficient power.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.3575</p_value>
            <p_value_desc>This is unadjusted.</p_value_desc>
            <method>Fisher Exact</method>
            <method_desc>Cell (1,1) Frequency (F) = 13</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>.2364</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.0239</ci_lower_limit>
            <ci_upper_limit>2.3394</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Abscess Measurement Using a Abscess Measurement Scale in Methicillin-resistant Staphylococcus Aureus (MRSA) Positive Patients.</title>
        <description>The Abscess Measurement Scale was measured using a centimeter ruler.
Scale 8cm – 10cm = Severe 6cm – 8cm = Moderate/severe 4cm – 6cm = Moderate 2cm – 4cm = Mild/moderate 0cm – 2cm = Mild</description>
        <time_frame>48 hours</time_frame>
        <population>Only participants that were MRSA-positive, were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>IRRISEPT</title>
            <description>Device containing sterile water and chlorhexidine gluconate (CHG)</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>The usual care method will either be the saline irrigation or incision and drainage depending on the physicians discretion.</description>
          </group>
        </group_list>
        <measure>
          <title>Abscess Measurement Using a Abscess Measurement Scale in Methicillin-resistant Staphylococcus Aureus (MRSA) Positive Patients.</title>
          <description>The Abscess Measurement Scale was measured using a centimeter ruler.
Scale 8cm – 10cm = Severe 6cm – 8cm = Moderate/severe 4cm – 6cm = Moderate 2cm – 4cm = Mild/moderate 0cm – 2cm = Mild</description>
          <population>Only participants that were MRSA-positive, were analyzed.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread=".5477"/>
                    <measurement group_id="O2" value="2.0">There was only one patient in this group.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Ho: There is not a significant difference between the use of IRRISEPT solution and the &quot;usual care methods&quot; on abscess healing in patients that are MRSA positive.
This study did not enroll an adequate number of patients to meet sufficient power.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.5415</p_value>
            <p_value_desc>This is unadjusted.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>Degrees of freedom = 4</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-.400</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>.5477</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.0659</ci_lower_limit>
            <ci_upper_limit>1.2659</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>02/26/2011 - 08/09/2012</time_frame>
      <group_list>
        <group group_id="E1">
          <title>IRRISEPT</title>
          <description>Device containing sterile water and chlorhexidine gluconate (CHG)</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>The usual care method will either be the saline irrigation or incision and drainage depending on the physicians discretion.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Increased Pain</sub_title>
                <description>Increased pain</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Richard F Petrik, MD</name_or_title>
      <organization>University of Florida</organization>
      <phone>352-265-5911</phone>
      <email>rpetrik@ufl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

